Keck School Faculty

Haris Zahoor
Haris Zahoor
Assistant Professor of Clinical Medicine
1500 San Pablo Street Health Sciences Campus Los Angeles

The importance of not only living longer but also better in the setting of advanced urothelial cancer Ann Transl Med. 2019 Sep; 7(Suppl 6):S187. . View in PubMed

Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer Invest New Drugs. 2019 Jun 24. . View in PubMed

Brain Injury-Mediated Neuroinflammatory Response and Alzheimer's Disease Neuroscientist. 2019 May 16; 1073858419848293. . View in PubMed

Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders J Neuroimmune Pharmacol. 2019 Apr 23. . View in PubMed

Mast Cell Proteases Activate Astrocytes and Glia-Neurons and Release Interleukin-33 by Activating p38 and ERK1/2 MAPKs and NF-? B. Mol Neurobiol. 2019 Mar; 56(3):1681-1693.. View in PubMed

CRISPR/Cas9 Editing of Glia Maturation Factor Regulates Mitochondrial Dynamics by Attenuation of the NRF2/HO-1 Dependent Ferritin Activation in Glial Cells J Neuroimmune Pharmacol. 2019 Feb 27. . View in PubMed

The Cancer Immunogram: A Pledge for a Comprehensive Biomarker Approach for Personalized Immunotherapy in Urothelial Cancer Eur Urol. 2019 03; 75(3):445-447. . View in PubMed

Evaluation of T cell infiltration in matched biopsy and nephrectomy samples in renal cell carcinoma Medicine (Baltimore). 2018 Sep; 97(37):e12344. . View in PubMed

Extended therapy breaks from VEGFR TKI therapy in renal cell carcinoma: Sometimes less is more Oncotarget. 2018 Mar 06; 9(18):14036-14037. . View in PubMed

Feasibility of Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer Patients With Diminished Renal Function Clin Genitourin Cancer. 2018 08; 16(4):e879-e892. . View in PubMed

Patient Characteristics, Treatment Patterns and Prognostic Factors in Squamous Cell Bladder Cancer Clin Genitourin Cancer. 2018 04; 16(2):e437-e442. . View in PubMed

Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumab J Immunother Cancer. 2018 10 17; 6(1):107. . View in PubMed

Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration Front Cell Neurosci. 2017; 11:216. . View in PubMed

Emerging growth factor receptor antagonists for the treatment of renal cell carcinoma Expert Opin Emerg Drugs. 2016 Dec; 21(4):431-440. . View in PubMed

Neuroinflammation Induces Neurodegeneration J Neurol Neurosurg Spine. 2016; 1(1). . View in PubMed

The revised American Joint Committee on Cancer staging system (7th edition) improves prognostic stratification after minimally invasive esophagectomy for esophagogastric adenocarcinoma Am J Surg. 2015 Oct; 210(4):610-7. . View in PubMed

Tumor associated PD-L1 expression pattern in microscopically tumor positive sentinel lymph nodes in patients with melanoma J Transl Med. 2015 Sep 30; 13:319. . View in PubMed

A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcinoma J Thorac Cardiovasc Surg. 2015 Feb; 149(2):538-47. . View in PubMed

Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-a but Not Observation in Intermediate Risk Melanoma Patients PLoS One. 2015; 10(7):e0132745. . View in PubMed

Baseline circulating IL-17 predicts toxicity while TGF-ß1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma J Immunother Cancer. 2015; 3:39. . View in PubMed

Phase I trial of carboplatin and etoposide in combination with panobinostat in patients with lung cancer Anticancer Res. 2013 Oct; 33(10):4475-81. . View in PubMed

Smoothened inhibition leads to decreased proliferation and induces apoptosis in esophageal adenocarcinoma cells Cancer Invest. 2013 Aug; 31(7):480-9. . View in PubMed

Powered by SC CTSI
Go to Top